BRIEF-Allergan CEO says considering share buyback
April 6 (Reuters) -
* Allergan CEO Saunders says committed to double-digit revenue growth in branded products
* Allergan CEO says everything is on the table including share buybacks and returning capital to shareholders
* Allergan CEO says Valeant's B&L is different enough than Allergan's, but unclear if it is a growth business that would be good M&A target
* Allergan CEO also says that Bausch & Lomb is not for sale (Reporting By Caroline Humer)
© Thomson Reuters 2017 All rights reserved.